UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Human IFT52 mutations uncover a novel role for the protein in microtubule dynamics and centrosome cohesion

Human molecular genetics, 2019-08, Vol.28 (16), p.2720-2737

2019

Link zum Volltext

Verfügbarkeit prüfen

A cyclic peptidic serine protease inhibitor: increasing affinity by increasing peptide flexibility

PloS one, 2014-12, Vol.9 (12), p.e115872

2014

Link zum Volltext

Verfügbarkeit prüfen

The Binding Mechanism of a Peptidic Cyclic Serine Protease Inhibitor

Journal of molecular biology, 2011-09, Vol.412 (2), p.235-250

2011

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a Site on PAI-1 That Binds to Vitronectin Outside of the Somatomedin B Domain

The Journal of biological chemistry, 2008-10, Vol.283 (42), p.28487-28496

2008

Link zum Volltext

Verfügbarkeit prüfen

A Urokinase-type Plasminogen Activator-inhibiting Cyclic Peptide with an Unusual P2 Residue and an Extended Protease Binding Surface Demonstrates New Modalities for Enzyme Inhibition

The Journal of biological chemistry, 2005-11, Vol.280 (46), p.38424-38437

2005

Link zum Volltext

Verfügbarkeit prüfen

A Peptide Accelerating the Conversion of Plasminogen Activator Inhibitor-1 to an Inactive Latent State

Molecular pharmacology, 2008-09, Vol.74 (3), p.641-653

2008

Link zum Volltext

Verfügbarkeit prüfen

Analysis of cortical cell polarity by imaging flow cytometry

Journal of cellular biochemistry, 2023-11, Vol.124 (11), p.1685-1694

2023

Link zum Volltext

Verfügbarkeit prüfen

Biochemical importance of glycosylation of plasminogen activator inhibitor-1

Thrombosis and haemostasis, 2003-08, Vol.90 (2), p.206

2003

Link zum Volltext

Verfügbarkeit prüfen

Crystal structure of tetrameric human Rabin8 GEF domain

Proteins, structure, function, and bioinformatics, 2018-04, Vol.86 (4), p.405-413

2018

Link zum Volltext

Verfügbarkeit prüfen

Very Low Density Lipoprotein Receptor Binds and Mediates Endocytosis of Urokinase-type Plasminogen Activator-Type-1 Plasminogen Activator Inhibitor Complex (∗)

The Journal of biological chemistry, 1995-09, Vol.270 (35), p.20855-20861

1995

Link zum Volltext

Verfügbarkeit prüfen

Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors

The Journal of biological chemistry, 2019-03, Vol.294 (10), p.3794-3805

2019

Link zum Volltext

Verfügbarkeit prüfen

Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved

Thrombosis and haemostasis, 2017, Vol.117 (9), p.1688

2017

Link zum Volltext

Verfügbarkeit prüfen

Distinctive binding modes and inhibitory mechanisms of two peptidic inhibitors of urokinase-type plasminogen activator with isomeric P1 residues

The international journal of biochemistry & cell biology, 2015-05, Vol.62, p.88-92

2015

Link zum Volltext

Verfügbarkeit prüfen

Bicyclic Peptide Inhibitor of Urokinase-Type Plasminogen Activator: Mode of Action

Chembiochem : a European journal of chemical biology, 2013-11, Vol.14 (16), p.2179-2188

2013

Link zum Volltext

Verfügbarkeit prüfen

Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs

Molecular pharmacology, 2011-10, Vol.80 (4), p.585-597

2011

Link zum Volltext

Verfügbarkeit prüfen

RNA Aptamers as Conformational Probes and Regulatory Agents for Plasminogen Activator Inhibitor-1

Biochemistry (Easton), 2010-05, Vol.49 (19), p.4103-4115

2010

Link zum Volltext

Verfügbarkeit prüfen

A Regulatory Hydrophobic Area in the Flexible Joint Region of Plasminogen Activator Inhibitor-1, Defined with Fluorescent Activity-neutralizing Ligands

The Journal of biological chemistry, 2001-04, Vol.276 (16), p.13077-13086

2001

Link zum Volltext

Verfügbarkeit prüfen

Inside Cover: Bicyclic Peptide Inhibitor of Urokinase-Type Plasminogen Activator: Mode of Action (ChemBioChem 16/2013)

Chembiochem : a European journal of chemical biology, 2013-11, Vol.14 (16), p.2062-2062

2013

Link zum Volltext

Verfügbarkeit prüfen

Nonproteolytic Induction of Catalytic Activity into the Single-Chain Form of Urokinase-Type Plasminogen Activator by Dipeptides

Biochemistry (Easton), 2009-10, Vol.48 (40), p.9606-9617

2009

Link zum Volltext

Verfügbarkeit prüfen

Evidence for a Pre-latent Form of the Serpin Plasminogen Activator Inhibitor-1 with a Detached β-Strand 1C

The Journal of biological chemistry, 2006-11, Vol.281 (47), p.36071-36081

2006

Link zum Volltext

Verfügbarkeit prüfen

Binding areas of urokinase‐type plasminogen activator–plasminogen activator inhibitor‐1 complex for endocytosis receptors of the low‐density lipoprotein receptor family, determined by site‐directed mutagenesis

The FEBS journal, 2006-11, Vol.273 (22), p.5143-5159

2006

Link zum Volltext

Verfügbarkeit prüfen

Ligand Binding Properties of the Very Low Density Lipoprotein Receptor

The Journal of biological chemistry, 1999-03, Vol.274 (13), p.8973-8980

1999

Link zum Volltext

Verfügbarkeit prüfen

Vitronectin in human breast carcinomas

Biochimica et biophysica acta, 2003-05, Vol.1638 (1), p.72-82

2003

Link zum Volltext

Verfügbarkeit prüfen

A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization

The Journal of biological chemistry, 2001-04, Vol.276 (16), p.13077-13086

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention:A prospective, randomized study

Pediatric allergy and immunology, 2000-08, Vol.11 (3), p.149-161

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(99)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(63)
Humans
(53)
Biochemistry & Molecular Biology
(24)
Female
(21)
Animals
(15)
Biological And Medical Sciences
(14)
Amino Acid Sequence
(13)
Models, Molecular
(13)
Adult
(12)
Binding Sites
(12)
Protein Binding
(11)
Male
(10)
Medical Sciences
(10)
Plasminogen Activator Inhibitor 1 - Metabolism
(10)
Kinetics
(9)
Plasminogen Activator Inhibitor 1 - Chemistry
(9)
Pregnancy
(9)
Molecular Sequence Data
(8)
Obstetrics & Gynecology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Human IFT52 mutations uncover a novel role for the protein in microtubule dynamics and centrosome cohesion

A cyclic peptidic serine protease inhibitor: increasing affinity by increasing peptide flexibility

The Binding Mechanism of a Peptidic Cyclic Serine Protease Inhibitor

Characterization of a Site on PAI-1 That Binds to Vitronectin Outside of the Somatomedin B Domain

A Urokinase-type Plasminogen Activator-inhibiting Cyclic Peptide with an Unusual P2 Residue and an Extended Protease Binding Surface Demonstrates New Modalities for Enzyme Inhibition

A Peptide Accelerating the Conversion of Plasminogen Activator Inhibitor-1 to an Inactive Latent State

Analysis of cortical cell polarity by imaging flow cytometry

Biochemical importance of glycosylation of plasminogen activator inhibitor-1

Crystal structure of tetrameric human Rabin8 GEF domain

Very Low Density Lipoprotein Receptor Binds and Mediates Endocytosis of Urokinase-type Plasminogen Activator-Type-1 Plasminogen Activator Inhibitor Complex (∗)

Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors

Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved

Distinctive binding modes and inhibitory mechanisms of two peptidic inhibitors of urokinase-type plasminogen activator with isomeric P1 residues

Bicyclic Peptide Inhibitor of Urokinase-Type Plasminogen Activator: Mode of Action

Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs

RNA Aptamers as Conformational Probes and Regulatory Agents for Plasminogen Activator Inhibitor-1

A Regulatory Hydrophobic Area in the Flexible Joint Region of Plasminogen Activator Inhibitor-1, Defined with Fluorescent Activity-neutralizing Ligands

Inside Cover: Bicyclic Peptide Inhibitor of Urokinase-Type Plasminogen Activator: Mode of Action (ChemBioChem 16/2013)

Nonproteolytic Induction of Catalytic Activity into the Single-Chain Form of Urokinase-Type Plasminogen Activator by Dipeptides

Evidence for a Pre-latent Form of the Serpin Plasminogen Activator Inhibitor-1 with a Detached β-Strand 1C

Binding areas of urokinase‐type plasminogen activator–plasminogen activator inhibitor‐1 complex for endocytosis receptors of the low‐density lipoprotein receptor family, determined by site‐directed mutagenesis

Ligand Binding Properties of the Very Low Density Lipoprotein Receptor

Vitronectin in human breast carcinomas

A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization

Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention:A prospective, randomized study

Suchergebnisse filtern